The RDAF hosted a Multi-Stakeholder Workshop on Registries for Rare Diseases

    30 Jun, 2021

    On 30 June 2021, the RDAF organized a multi-stakeholder workshop on Swiss registries for rare diseases. Actors from patient organizations, industry, politician, research organizations, healthcare professionals and legal expert shared their perspectives about the current status, opportunities and challenges for rare diseases registries.

    Shayesteh Fürst-Ladani, President of the RDAF, said ‘I am glad that actors across the field of rare diseases accepted our invitation to take part in this multi-stakeholder event. Finding consensus for united actions is a prerequisite to achieve our common goal to improve the conditions for patients with rare diseases in Switzerland’.

    The next RDAF workshop will take place in September. More information will be available on the RDAF website in due time.

    Continue reading

    Ipsen joins the Rare Disease Action Forum

    We are proud to welcome Ipsen as the newest member of the Rare Disease Action Forum. Reinforcing RDAF’s multi-stakeholder approach, they will be joining our other members including industry, patient organizations, healthcare professionals, and research organizations....

    UCB Pharma and HOPOS join the Rare Disease Action Forum

    We are proud to welcome UCB Pharma and HOPOS as the newest members of the Rare Disease Action Forum. Reinforcing RDAF’s multi-stakeholder approach, they will be joining our other members including industry, patient organizations, healthcare professionals, and research...